It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
Challenges and opportunities for use of cost-effectiveness analysis.
https://arctichealth.org/en/permalink/ahliterature149223
Source
J Natl Cancer Inst. 2009 Sep 2;101(17):1161-3
Publication Type
Article
Date
Sep-2-2009
More detail
Author
K Robin Yabroff
Deborah Schrag
Source
J Natl Cancer Inst. 2009 Sep 2;101(17):1161-3
Date
Sep-2-2009
Language
English
Publication Type
Article
Keywords
Antibodies, Monoclonal - economics - therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents - economics - therapeutic use
Canada
Colorectal Neoplasms - drug therapy - economics
Cost-Benefit Analysis
Drug Costs
Great Britain
Health Care Costs
Humans
Mutation
Patient Selection
Proto-Oncogene Proteins - analysis - genetics
Quality-Adjusted Life Years
Tumor Markers, Biological - analysis - genetics
United States
ras Proteins - analysis - genetics
Notes
Comment On: J Natl Cancer Inst. 2009 Sep 2;101(17):1182-9219666851
PubMed ID
19666852
View in PubMed
Less detail
Permalink